These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 7663405)
1. Interaction of indole derivatives with monoamine oxidase A and B. Studies on the structure-inhibitory activity relationship. Medvedev AE; Ivanov AS; Kamyshanskaya NS; Kirkel AZ; Moskvitina TA; Gorkin VZ; Li NY; Marshakov VYu Biochem Mol Biol Int; 1995 May; 36(1):113-22. PubMed ID: 7663405 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of monoamine oxidase by C5-substituted phthalimide analogues. Manley-King CI; Bergh JJ; Petzer JP Bioorg Med Chem; 2011 Aug; 19(16):4829-40. PubMed ID: 21778064 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of monoamine oxidase by indole and benzofuran derivatives. Prins LH; Petzer JP; Malan SF Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099 [TBL] [Abstract][Full Text] [Related]
4. Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors. Tripathi RK; Krishnamurthy S; Ayyannan SR ChemMedChem; 2016 Jan; 11(1):119-32. PubMed ID: 26592797 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues. Manley-King CI; Bergh JJ; Petzer JP Bioorg Med Chem; 2011 Jan; 19(1):261-74. PubMed ID: 21134756 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B. La Regina G; Silvestri R; Gatti V; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E Bioorg Med Chem; 2008 Nov; 16(22):9729-40. PubMed ID: 18951803 [TBL] [Abstract][Full Text] [Related]
7. Selective inhibitors and computer modelling of the active site of monoamine oxidase. Medvedev AE; Ivanov AS; Veselovsky AV Neurobiology (Bp); 2000; 8(2):201-14. PubMed ID: 11061215 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of brain mitochondrial monoamine oxidases by the endogenous compound 5-hydroxyoxindole. Crumeyrolle-Arias M; Tournaire MC; Cane A; Launay JM; Barritault D; Medvedev A Biochem Pharmacol; 2004 Mar; 67(5):977-9. PubMed ID: 15104251 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoamine oxidase by indole-5,6-dicarbonitrile derivatives. Chirkova ZV; Kabanova MV; Filimonov SI; Abramov IG; Petzer A; Petzer JP; Firgang SI; Suponitsky KY Bioorg Med Chem Lett; 2015 Mar; 25(6):1206-11. PubMed ID: 25701250 [TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor. Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674 [TBL] [Abstract][Full Text] [Related]
14. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling. Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832 [TBL] [Abstract][Full Text] [Related]
15. Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors. Shi L; Yang Y; Li ZL; Zhu ZW; Liu CH; Zhu HL Bioorg Med Chem; 2010 Feb; 18(4):1659-64. PubMed ID: 20117937 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: effects of lipophilicity and structure-activity relationships. Altomare C; Cellamare S; Summo L; Catto M; Carotti A; Thull U; Carrupt PA; Testa B; Stoeckli-Evans H J Med Chem; 1998 Sep; 41(20):3812-20. PubMed ID: 9748356 [TBL] [Abstract][Full Text] [Related]
17. Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B. Yoshida S; Rosen TC; Meyer OG; Sloan MJ; Ye S; Haufe G; Kirk KL Bioorg Med Chem; 2004 May; 12(10):2645-52. PubMed ID: 15110846 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase. Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides. Manley-King CI; Terre'Blanche G; Castagnoli N; Bergh JJ; Petzer JP Bioorg Med Chem; 2009 Apr; 17(8):3104-10. PubMed ID: 19324554 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]